TTY combines an extensive understanding of the regulatory approval process with an exemplary regulatory history to fully support our pharmaceutical development programs.
TTY has much experience in in-house preparation of Modules 2 and 3 (CMC) drafts of the Common Technical Document (CTD). Several oncology injections have approved by EMA.